Canopy Growth Corporation (TSX:WEED)
Canada · Delayed Price · Currency is CAD | Market Cap | 499.18M -24.5% |
| Revenue (ttm) | 293.63M +6.8% |
| Net Income | -232.63M |
| EPS | -0.65 |
| Shares Out | 423.04M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 785,188 |
| Open | 1.210 |
| Previous Close | 1.210 |
| Day's Range | 1.170 - 1.210 |
| 52-Week Range | 1.170 - 3.280 |
| Beta | 2.37 |
| Analysts | Hold |
| Price Target | 2.02 (+71.19%) |
| Est. Earnings | Nov 6, 2026 |
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-... [Read more]
Full Company ProfileFinancial Performance
In fiscal year 2026, Canopy Growth's revenue was 284.60 million, an increase of 5.80% compared to the previous year's 269.00 million. Losses were -262.91 million, -48.34% less than in 2025.
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for WEED stock is "Hold." The 12-month stock price target is $2.02, which is an increase of 71.19% from the latest price.
News
Can Canopy Growth Survive Another 5 Years?
Canopy Growth burned through a significant amount of cash last quarter. The company's poor financials are a big reason why the stock has cratered.
Canopy Growth Proxy statement: Proxy filing
Canopy Growth filed a proxy statement on October 6, 2026, providing details for shareholder voting and corporate governance matters.
Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors
Canopy Growth Corporation (CGC) reached $0.88 at the closing of the latest trading day, reflecting a -1.54% change compared to its last close.
Canopy Growth Is Closing in on Positive EBITDA. Should You Buy the Stock?
Positive adjusted EBITDA could mark an important turnaround milestone. Sustained revenue growth could strengthen Canopy's investment case.
Canopy Growth appoints Sebastian Blote as country manager for Germany
Canopy Growth (CGC) announced the appointment of Sebastian Blote as Country Manager for Germany, effective October 1, 2026. Blote will lead Canopy Growth’s commercial strategy in Germany, with respons...
Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives throu...
Canopy Growth Corp Annual Shareholders Meeting Transcript
Canopy Growth Corp Annual Shareholders Meeting Transcript
Canopy Growth Corporation (CGC) Rises Higher Than Market: Key Facts
Canopy Growth Corporation (CGC) closed at $0.94 in the latest trading session, marking a +1.45% move from the prior day.
Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives throu...
Canopy Growth Transcript: AGM 2026
The meeting opened virtually with introductions and instructions for participation. Due to lack of quorum, no business or voting occurred, and the meeting was adjourned to a later date in October.
Canopy Growth Proxy statement: Proxy filing
Canopy Growth filed a proxy statement on September 25, 2026, providing details for shareholder voting and corporate governance matters.
Canopy Growth Is Eyeing Another Reverse Stock Split. Will It Be Enough to Light a Fire Beneath the Beaten-Down Pot Stock?
On Sept. 25, Canopy Growth investors will be asked to vote on a reverse stock split. Currently trading below $1, the company could risk being delisted if a reverse split isn't enacted.
Canopy Growth extends proxy voting deadline for annual general, special meeting
Canopy Growth (CGC) has extended the proxy voting deadline for its upcoming Annual General and Special Meeting of shareholders to 12:00 p.m. ET on Friday, September 25. The Meeting will…
Canopy Growth Announces Extension of Proxy Voting Deadline for 2026 Annual General and Special Meeting
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives throu...
Canopy Growth expands European medical cannabis supply into the UK
Canopy Growth (CGC) will supply four Canadian-grown medical cannabis flower strains for distribution in the United Kingdom, expanding the reach of its international cannabis business into another Euro...
Canopy Growth Expands European Medical Cannabis Supply Into the UK
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives throu...
Here is What to Know Beyond Why Canopy Growth Corporation (CGC) is a Trending Stock
Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Canopy Growth Proxy statement: Proxy filing
Canopy Growth filed a proxy statement on September 15, 2026, providing details for shareholder voting and corporate governance matters.
Canopy Growth Corporation (CGC) Advances While Market Declines: Some Information for Investors
Canopy Growth Corporation (CGC) reached $0.94 at the closing of the latest trading day, reflecting a +1.15% change compared to its last close.
Canopy Growth's Business Is Improving. So Why Isn't the Stock Performing Better?
Two long-standing issues continue to weigh on this cannabis stock.
Canopy Growth reminds shareholders vote ‘FOR’ items 1 through 6
Canopy Growth (CGC) Corporation reminds shareholders to vote ahead of its Annual General and Special Meeting of shareholders. “The board of directors of the Company recommends shareholders vote FOR It...
Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadline
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives throu...
Canopy Growth broadens medical cannabis portfolio in Australia
Canopy Growth (CGC) announced a broadening of its medical cannabis portfolio in Australia across its Spectrum Therapeutics, Spectrum Therapeutics Reserve, 7ACRES, Tweed and Twd. brands. The expansion ...
Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulations
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives throu...
Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted.
Canopy Growth's revenue increased 13% year over year in its most recent fiscal quarter. Adjusted gross margin improved, while EBITDA losses narrowed sharply.